New search Hide text from Guidelines
N NERVOUS SYSTEMN04 ANTI-PARKINSON DRUGS
This group comprises preparations used in the treatment of Parkinsons disease and related conditions, including drug-induced parkinsonism.
| The DDDs are based on recommended doses for the long-term treatment of symptoms of Parkinsons disease. No separate DDDs are established for oral depot formulations. |
N04A ANTICHOLINERGIC AGENTS
N04AA Tertiary amines
N04AB Ethers chemically close to antihistamines
Orphenadrine chloride is classified in this group, while orphenadrine citrate is classified in M03BC.
N04AC Ethers of tropine or tropine derivatives
Last updated: 2024-01-26